Scarica l'app Stockscreener
1.95
8.45%
-0.18
Dopo l'orario di chiusura:
1.96
0.01
+0.51%
Precedente Chiudi:
$2.13
Aprire:
$2.13
Volume 24 ore:
4.13M
Relative Volume:
0.84
Capitalizzazione di mercato:
$72.98M
Reddito:
-
Utile/perdita netta:
$-57.91M
Rapporto P/E:
-1.3938
EPS:
-1.3991
Flusso di cassa netto:
$-38.14M
1 W Prestazione:
+9.55%
1M Prestazione:
+41.82%
6M Prestazione:
-86.56%
1 anno Prestazione:
-68.14%
Intervallo 1D:
$1.95
$2.14
Intervallo di 1 settimana:
$1.80
$2.22
Portata 52W:
$1.31
$19.40
Tenax Therapeutics Inc Stock (TENX) Company Profile
Nome
Tenax Therapeutics Inc
Settore
Industria
Telefono
919-855-2100
Indirizzo
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Compare TENX vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
1.95 | 79.71M | 0 | -57.91M | -38.14M | -1.3991 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-09-08 | Iniziato | Piper Sandler | Overweight |
| 2024-10-24 | Iniziato | Leerink Partners | Outperform |
| 2024-10-14 | Iniziato | Guggenheim | Buy |
| 2024-09-30 | Iniziato | William Blair | Outperform |
| 2017-05-18 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | Iniziato | MLV & Co | Buy |
| 2014-11-18 | Iniziato | WallachBeth | Buy |
Mostra tutto
Tenax Therapeutics Inc Borsa (TENX) Ultime notizie
Cantor Fitzgerald reiterates Tenax Therapeutics stock rating at overweight By Investing.com - Investing.com Canada
Tenax at Cantor conference: trial miss sharpens next-step strategy By Investing.com - Investing.com India
Tenax Therapeutics Updates Phase 3 LEVEL Trial Strategy - TipRanks
Adar1 Capital Management, 10% owner, buys $1.6m in Tenax Therapeutics - Investing.com Australia
Adar1 Capital Management, 10% owner, buys $1.6m in Tenax Therapeutics By Investing.com - Investing.com South Africa
ADAR1 Capital Management, LLC Expands Tenax Therapeutics Inc (TENX) Stake in Strategic Add - GuruFocus
One manager just reported a 14% holding in Tenax Therapeutics (TENX) - Stock Titan
FMR LLC reports 514,925-share stake in Tenax (NASDAQ: TENX) - Stock Titan
TENX Jumps As Tenax Therapeutics Pivots Phase 3 Strategy - timothysykes.com
Tenax Therapeutics Stock Wobbles After Mixed Phase 3 Data - timothysykes.com
Tenax Therapeutics Inc (NASDAQ: TENX) Share Price, TENX Stock News, TENX Share Price & Updates - Kalkine
Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable? - Yahoo Finance
Sphera Funds Management Boosts Tenax Therapeutics Stake in High-Risk Biotech Bet - GuruFocus
Investment funds tied to Tenax (TENX) 10% owner just bought more stock - Stock Titan
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - Stock Titan
TENX Downgraded by Guggenheim -- Rating Updated to Neutral - GuruFocus
Piper Sandler Maintains Tenax Therapeutics(TENX.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Guggenheim Downgrades TENX to Neutral Amid Uncertain Clinical Ou - GuruFocus
Why is Tenax Therapeutics stock volatile today? By Investing.com - Investing.com Canada
Tenax Therapeutics (TENX) Phase 3 Data Spurs Focus on Subgroup B - GuruFocus
Tenax finds benefit in sicker patient subgroup after Phase 3 trial miss (TENX:NASDAQ) - Seeking Alpha
Tenax presents additional Phase 3 trial data for TNX-103 By Investing.com - Investing.com Nigeria
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 - Investing News Network
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL - GlobeNewswire
ING Groep reveals passive stake in Tenax Therapeutics (ING) - Stock Titan
New 5.3% backer emerges in Tenax Therapeutics (NASDAQ: TENX) - Stock Titan
Tenax Therapeutics Stock (TENX) Opinions on Recent Insider Purchases and Gains - quiverquant.com
Tenax rises on over $1.8M insider buying (TENX:NASDAQ) - Seeking Alpha
ADAR1 Capital Management, LLC Expands Tenax Therapeutics Inc (TE - GuruFocus
Adar1 Capital Management buys $1.8m of Tenax Therapeutics (TENX) shares - Investing.com Canada
Millennium Management Boosts Tenax Therapeutics Stake Despite St - GuruFocus
Price to book forward of Tenax Therapeutics, Inc. – NASDAQ:TENX - TradingView
Price to book forward of Tenax Therapeutics, Inc. – HAM:YBO0 - TradingView
Enterprise value of Tenax Therapeutics, Inc. – HAM:YBO0 - TradingView
Total revenue of Tenax Therapeutics, Inc. – HAM:YBO0 - TradingView
RTW Investments, LP Expands Tenax Therapeutics (TENX) Stake Desp - GuruFocus
Tenax Therapeutics (TENX) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Israel Englander funds hold over 5% of Tenax Therapeutics (TENX) - Stock Titan
TENX Q2 2026 Earnings: Narrower Loss Per Share Fails to Offset Stock DeclineEPS Revision Trend - vinanet.vn
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Tenax Therapeutics (TENX) - GlobeNewswire
TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law - The AI Journal
Price-Driven Insight from (TENX) for Rule-Based Strategy - Stock Traders Daily
symbol__ Stock Quote Price and Forecast - CNN
Tenax Therapeutics (NASDAQ:TENX) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeat
Ikarian Capital (TENX) discloses 2.9% beneficial stake in Tenax Therapeutics common stock - Stock Titan
Venrock group (TENX) discloses 1.57M-share warrant-based stake in Tenax - Stock Titan
Perceptive Advisors (TENX) reports beneficial ownership of 1.7M Tenax Therapeutics shares - Stock Titan
Tenax Therapeutics (TENX) holder BVF reports 3.11M shares, big warrant overhang - Stock Titan
Vivo Opportunity discloses 9% Tenax Therapeutics (TENX) holding via stock and warrants - Stock Titan
TENX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Tenax Therapeutics (TENX) - Business Wire
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Tenax Therapeutics Inc Azioni (TENX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):